Event Participants
Executives
4
Ankush Chan (CFO), Harjeet (India Business), Mohit Malhotra (Global CEO), Rahul Sarawagi (Head - IR & M&A)
Analysts
3
Abneesh Roy (Nuvama), Aditya Soman (CLSA), Prakash Kapadia (Kapadia Financial)
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Consolidated Revenue Growth | +10.6% YoY | Broad-based growth across India and international businesses in Q1 FY27 |
| India FMCG Revenue Growth | +9.5% YoY | Backed by volume growth of 5%; rural outpaced urban by ~550 bps |
| Volume Growth (India FMCG) | +5% YoY | Rural momentum continued despite weather disruptions and inflation |
| International Business Growth | +15.5% YoY (INR terms) | MENA +9%, UK/EU +22%, Egypt +28%, Turkey +27%, Bangladesh +34%, despite Middle East war |
| HPC Portfolio Growth | +12.3% YoY | Continued strong momentum; led by hair care and oral care |
| Hair Oil Growth | High-teens YoY (~18%) | ~8% volume growth; gained 102 bps market share; GST and crude-linked price increases |
| Shampoo Portfolio Growth | Strong double-digit YoY | Vatika launched Bio Infusions – India's first no added-salt shampoo range |
| Honey Growth | High single-digit YoY | Gained 150 bps market share; premium variants (Sunderbans, Organic) growing well |
| Active Juices / Coconut Water Growth | >40% / >70% YoY | Gained ~600 bps and 344 bps market share respectively on premiumization |
| Foods Business Growth | ~30% YoY | Volume-led double-digit growth |
| Badshah Growth | +13.3% YoY | ~11% domestic volume growth; international business +40%+ |
| Operating Profit Growth | +11% YoY | Ahead of top line; premiumization, productivity initiatives and disciplined cost management |
| Profit After Tax Growth | +15% YoY | Ahead of top line growth; resilient business model |
| Net Cash & Investments | ~₹9,000 crores | ~₹6,500 crores in India; 100% of India PAT returned as dividend |
Geographic & Segment Commentary
India (Domestic FMCG): Revenue grew 9.5% with 5% volume growth; HPC portfolio +12.3%; rural outpaced urban by ~550 bps on TT basis. F&B grew high single digit despite unseasonal April rains, with beverages recovering to mid-teens growth in May–June and foods growing ~30%.
International Business: Grew 15.5% in INR terms despite continued Middle East war impact; MENA +9%, UK/EU +22%, Egypt +28%, Turkey +27%, Bangladesh +34%; dollar-denominated markets provide an incremental currency tailwind.
Hair Care: Hair oils grew high teens (~18%) with ~8% volume and 102 bps market share gain; shampoos delivered strong double-digit growth, led by Vatika Bio Infusions – India's first no added-salt shampoo range – reflecting science-backed innovation and premiumization.
Oral Care: Near double-digit growth led by red franchise, Miswak, Dabur Herbal and La Dant Manjan (double digit); herbal segment outperformed non-herbal by 550 bps, with further toothpaste market share gains.
Health Care: Honey gained 150 bps share on high single-digit growth; Pudin Hara double digit with encouraging response to new 5-in-1 variant; Hajmola near double digit; Isabgol strong double digit; Honitus +25%; glucose impacted by April rains but recovered to mid-teens/high-teens growth in May–June; Science nutraceutical brand grew 3x.
Home Care: Mid-single-digit growth; O'Donnell high single digit despite supply shortages (+80 bps share); camphor cones and car fresheners witnessing encouraging consumer acceptance.
Skincare: High single-digit growth driven by Gulabari franchise and OxyLife premium range, reflecting relevance of premium skincare offering.
Foods & Beverages: Active juices +40% and coconut water +70% drove category outperformance on premiumization; ~600 bps and 344 bps market share gains respectively; foods business grew ~30% volume-led.
Company-Specific & Strategic Commentary
Premiumization & Innovation: Premium variants (active juices, coconut water, Sunderbans/Organic honey) driving growth and margin expansion; new launches include Vatika Bio Infusions, Pudin Hara 5-in-1, camphor cones and car fresheners. Science is positioned as a disruptive D2C nutraceutical play with ~₹50 crores exit run-rate expected by end of FY27.
Badshah Geographic Expansion: Presence expanded beyond Gujarat and Maharashtra into MP, Rajasthan and Delhi NCR; e-commerce/quick commerce accounts for ~6% of Badshah turnover and is growing triple digits; brand scaled from ~₹200–220 crores at acquisition to ~₹400 crores exit run-rate.
Go-to-Market (Saksham): Transformation initiative expected to drive sequential acceleration in revenue growth in quarters ahead, alongside sustained brand building.
Capital Allocation & M&A: Net cash
₹9,000 crores (₹6,500 crores in India); strategy spans M&A, ₹500 crores earmarked for Dabur Ventures D2C investments (minority-to-majority approach), ₹400–500 crores Tamil Nadu greenfield capex and 100% of India PAT as dividends; targeting 1–2 sizable acquisitions within a three-year horizon, with 2–3 companies currently under discussion.Brand Building: Hair care campaign (Deepika Padukone) driving trial generation, penetration and market share gains; almost every second household in the Hindi belt is now a Dabur hair oil user.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Consolidated Revenue Growth | Double-digit growth for FY27 | Reconfirmed; price-led with volume lagging; international currency tailwind from dollar-denominated Middle East markets |
| Operating Margins | Better than last year (FY27) | Supported by premiumization, productivity initiatives and cost discipline; contingent on Middle East war and crude-linked inflation |
| Volume Growth | Below value/revenue growth | Inflation pass-through will keep volumes under pressure (e.g., hair oils ~8% volume vs ~18% value) |
| India Business Growth | Sequential acceleration expected | Rural momentum + monsoon recovery (~14–15% deficit remaining) support improving demand outlook |
| International Business | Continued double-digit growth | MENA, Egypt, Turkey, Bangladesh momentum; close monitoring of Middle East developments |
Risks & Constraints
| Risk | Context |
|---|---|
| Middle East Geopolitical Situation | War-related disturbances are impacting input cost trends and supply chain efficiency across businesses, including India; management remains in "wait and watch" mode if the conflict continues |
| Input Cost Inflation | Elevated inflation across several input categories; crude-linked and GST-driven price increases (e.g., hair oils) are being passed through, with volume growth as the trade-off |
| Monsoon Variability | Unseasonal April rains disrupted glucose and beverages; ~14–15% rainfall deficit remains despite recent coverage – a key swing factor for rural demand and kharif output |
| Spice Market Competition | Multiple listed FMCG players have entered the spices category; regional taste differences challenge Badshah's expansion, partially offset by e-commerce/quick commerce growth |
| Category Seasonality | Glucose and juice performance is weather-dependent; management views the April disruption as seasonal rather than structural, citing May–June recovery |
Q&A Highlights
Badshah Business Performance & Expansion
- Question: Has Badshah expanded beyond its original two states; is double-digit growth sufficient in a crowded spice market with differentiation concerns? (Abneesh Roy)
- Answer: Badshah grew 13.3% with ~11% domestic volume growth and 40%+ international growth; expanded from Gujarat/Maharashtra to MP, Rajasthan and Delhi NCR; e-commerce/quick commerce ~6% of turnover and growing triple digits; business now at ~₹400 crores exit run-rate vs ₹200–220 crores at acquisition. (Mohit Malhotra)
Glucose & Juices – Seasonal vs Structural
- Question: Did glucose see May–June recovery or is there a structural shift to energy drinks; is the fruit juice disruption behind? (Abneesh Roy)
- Answer: Glucose is seasonal, not structural – saw mid-teens/high-teens growth in May–June; 100% juices +45%, coconut water +70%, fizz portfolio +30–35% led by Hajmola Fizz; nectar turned profitable in the second half of the quarter. (Mohit Malhotra)
D2C Acquisition Strategy & Disruptive Innovation
- Question: What is the timeline for deploying the ₹500 crores D2C acquisition kitty; what disruptive innovations have achieved scale? (Abneesh Roy)
- Answer: Two-pronged approach – minority stake first, majority once profitable; targeting 1–2 sizable acquisitions within a three-year vision; currently in discussions with 2–3 companies. Science nutraceutical brand is the key disruptive play, with ~₹50 crores exit run-rate expected by year-end. (Mohit Malhotra)
New India Business Head – Initial Assessment
- Question: Three months in, what are the strengths and areas of improvement? (Abneesh Roy)
- Answer: Focus has been on induction, listening, learning and connecting with people; distribution strength, people passion and consumer love/trust are key assets; results are consistent with the last three quarters; will share a detailed view later in the year. (Harjeet)
Hair Oil Volumes & FY27 Growth Outlook
- Question: What is the volume growth in hair oils given sharp price inflation; how will FY27 growth shape up as the base toughens? (Aditya Soman)
- Answer: Hair oils grew ~18% value with 8% volume – roughly 50/50 price/volume; GST and crude-linked price increases passed on; confident of double-digit hair oil growth. FY27 consolidated revenue target is double-digit, with margins better than last year; international currency adds a tailwind. (Mohit Malhotra)
Monsoon, Rural Demand & Capital Allocation
- Question: What is the India outlook given monsoon patterns; any thoughts on the large cash pile and returning capital? (Prakash Kapadia)
- Answer: Monsoon deficit narrowed to
14–15% after last fortnight's rains, auguring well for kharif; rural ahead of urban by ~550 bps for Dabur. Net cash ~₹9,000 crores (₹6,500 crores in India) will be deployed toward M&A, 100% of India PAT as dividends, ₹400–500 crores Tamil Nadu greenfield capex and ₹500 crores Dabur Ventures. (Mohit Malhotra)
Price-Led Growth & Volume Trajectory
- Question: If double-digit volume comes through, can 14–15% consolidated growth sustain? (Prakash Kapadia)
- Answer: Volume will not be double-digit – top line will be more price-driven; volumes will remain under pressure from inflation. If the Middle East war ends and crude eases, double-digit profitable growth in line with top line is achievable; if the war continues, it is a "wait and watch" situation. (Mohit Malhotra)
Key Takeaway
Dabur delivered a strong start to FY27 with consolidated revenue growth of 10.6%, India FMCG up 9.5% (5% volume) and international up 15.5% in INR terms despite Middle East disruptions. Operating profit grew 11% and PAT 15%, ahead of revenue, on premiumization, productivity and cost discipline. Hair oils grew high teens with 102 bps share gain; active juices +40%, coconut water +70%, foods ~30%; nutraceutical brand Science tripled, targeting ~₹50 crores exit run-rate. Management reaffirmed double-digit consolidated revenue guidance for FY27 with margins better than last year, though volumes will lag value growth on price pass-through. Strategy centers on Saksham go-to-market transformation, premiumization-led innovation (Vatika Bio Infusions, Pudin Hara 5-in-1) and Badshah expansion into MP, Rajasthan and Delhi NCR. Capital allocation priorities deploy ~₹9,000 crores net cash toward ₹500 crores Dabur Ventures, ₹400–500 crores Tamil Nadu greenfield, 100% India PAT dividends and 1–2 sizable D2C acquisitions over three years. Watch points: Middle East war, crude-linked inflation, monsoon trajectory and glucose/juice seasonality.